Skip to main content
NKMAX Co., Ltd. logo

NKMAX Co., Ltd. — Investor Relations & Filings

Ticker · 182400 ISIN · KR7182400002 KO Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2020-12-03 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 182400

About NKMAX Co., Ltd.

https://nkmax.com/

NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party allocation of convertible preferred shares). It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2020-12-03 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a private placement of convertible bonds). It details the issuance amount, payment date, and the nature of the securities. This falls under the category of capital and financing updates as it relates to the company's capital structure and fundraising activities.
2020-11-30 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). It details the terms of the bond, including interest rates, maturity, conversion rights, and the list of investors. This falls under the category of capital and financing updates.
2020-11-26 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a decision for a third-party paid-in capital increase (유상증자결정) by NKMAX Co., Ltd. It details the number of shares, issuance price, purpose of funds, and the specific third-party investors involved. This type of filing is a formal regulatory disclosure concerning capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2020-11-26 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company NKMAX, covering the period from January 1, 2020, to September 30, 2020. It contains detailed financial information, corporate history, capital structure, and management details, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used by major shareholders or insiders to report changes in their shareholdings. Since the document details specific transactions (buy/sell) by a major shareholder (Korea Investment Value Asset Management) in the issuer (NKMAX), it falls under the category of 'Major Shareholding Notification' (MRQ) as it tracks changes in significant ownership levels.
2020-10-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.